Assistant Professor
Hematology
Dr. Loretta J. Nastoupil, MD
|
|
Give Review
Loretta J. Nastoupil, MD practices Hematology. She went to University of Texas Southwestern Medical School. Loretta Nastoupil is a published MD. She has 23 papers published. The most current publication "Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review." Loretta Nastoupil accepts Medicare payments and is listed with Medicare.gov.
Publications
- Outcomes following watchful waiting for stage II-IV follicular Lymphoma patients in the modern era.
- Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review.
- A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgki...
- Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin Lymphoma.
- Comparing the Cost-Effectiveness of Rituximab Maintenance and Radioimmunotherapy Consolidation versus Observation Following First-Line Therapy in Patients with Follicu...
- Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin Lymphoma.
- Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma.
- Safety and activity of lenalidomide and rituximab in untreated indolent Lymphoma: an open-label, phase 2 trial.
- Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular Lymphoma used in the United States.
- Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell Lymphoma.
- Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin Lymphoma.
- Socioeconomic disparities in Lymphoma.
- Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
- The use and effectiveness of rituximab maintenance in patients with follicular Lymphoma diagnosed between 2004 and 2007 in the United States.
- Insurance status is related to diffuse large B-cell Lymphoma survival.
- The role of chemotherapy in managing chronic lymphocytic leukemia: optimizing combinations with targeted therapy.
- Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin Lymphoma.
- Patterns of Failure in Advanced Stage Diffuse Large B-cell Lymphoma Patients After Complete Response to R-CHOP Immunochemotherapy and the Emerging Role of Consolidativ...
- Using primary site as a predictor of survival in mantle cell Lymphoma.
- Initial management strategies for follicular Lymphoma.
- Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma.
- Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Schools
University of Texas Southwestern Medical Center At Dallas
Conditions Treated
- Anemia
- Breast Cancer
- Deep Vein Thrombosis (DVT)
- Hodgkin's Disease
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Emory University -
Washington University - Barnes-Jewish Hospital -
University of Texas Southwestern Medical School
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1407048630 | |
| NPPES Provider LastName | NASTOUPIL | |
| NPPES Provider FirstName | LORETTA | |
| NPPES Provider ZIPCode | 770304000 | |
| NPPES Provider State | TX | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 199.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 6.03 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1407048630 |
| Last Name Of The Provider | NASTOUPIL |
| First Name Of The Provider | LORETTA |
| View All |
Similar Doctors
|
Dr. Nadya Hasham-Jiwa, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank V. Fossella, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Agop Y. Bedikian, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Margaret E. Van Meter, MD |
|
|
Dr. Ahmed Eid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George Carrum, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David Hui, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Bryan K. Kee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kanwal P. Raghav, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ken H. Young, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Nicholas E. Papadopoulos, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Gauri R. Varadhachary, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Chitra Balasundaram, MD |
|
|
Dr. George R. Elias, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joe L. Moake, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Pei Lin, MD |
|
|
Dr. Marguerite M. Rosales, MD
This Doctor is OpenDoctor Recommended.
|
|
|
David T. Kang |